You’re viewing the web version of STAT's ADA in 30 Seconds newsletter from the American Diabetes Association’s annual…
Healthcare spending projections are often inaccurate. This problem is amplified when (possibly wrong) estimates inform decisions related to…
Get your daily dose of health and medicine every weekday with STAT’s free newsletter Morning Rounds. Sign up…
Approximately 12% of adults in the United States take GLP-1 drugs like Ozempic, Mounjaro, Zepbound, or Wegovy, as…
The healthcare industry is constantly evolving, with new developments and challenges arising every day. Keeping up with the…
Public Citizen has recently petitioned the Trump administration to take action using a federal law to allow for…
Morning Rounds is a daily newsletter that provides updates on health and medicine. The latest edition covers a…
Endocrinologist Mary Elizabeth Patti understands that treating patients with type 2 diabetes goes beyond just looking at body…
The world of health and medicine is constantly evolving, and staying informed is crucial to making the best…
President Trump made a bold promise on Oct. 16 to reduce the price of brand-name GLP-1 drugs like…
Theresa Gaffney, the lead Morning Rounds writer, provides insightful reporting on health care, new research, and public policy,…
They do show, however, that the cost-effectiveness of these medications may not be as straightforward as previously thought.…
Sign in to your account